Immunotherapy and gene therapy in prostate cancer treatment • JML Journal of Medicine and Life

2017, Volume 10, Issue 1, pp 54 – 55

Immunotherapy and gene therapy in prostate cancer treatment

Issues

Special Issues

Authors and Affiliations

Grozescu T ^*

Popa F ^*

* *“Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania

Correspondence to: Traian Grozescu, MD, Department of Genetics, “Carol Davila” University of Medicine and Pharmacy, Bucharest, 8 Eroii Sanitari Blvd., District 5, Code 050474, Bucharest, Romania, Mobile phone: +40769 911 622, E-mail: dr.grozescu@gmail.com

Abstract

There are few methods bringing several relatively recent advances in therapy of certain types of prostate cancer. Belonging to personalized therapies, they use cells (normal or pathologic) from the patient, modify and reintroduce them in the patient’s body, leading to an increased efficiency against the neoplastic tissue, proving to increase the patient’s lifespan and/ or tumor progression.

Keywords

immunotherapyprostate cancer treatmentlifespanneoplastic tissuegene therapy

Preview

JMedLife-10-54

Download PDF

About this article

PMC ID: 5304374
PubMed ID: 28255378
DOI:

Article Publishing Date (print): Jan-Mar 2017
Available Online:

Journal information

ISSN Printing: 1844-122X
ISSN Online: 1844-3117
Journal Title: Journal of Medicine and Life

Copyright License: Open Access

This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use and redistribution provided that the original author and source are credited.